BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190212
DTEND;VALUE=DATE:20190214
DTSTAMP:20260515T013656
CREATED:20190124T073216Z
LAST-MODIFIED:20190124T073216Z
UID:19191-1549929600-1550102399@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials West Coast 2019
DESCRIPTION:After record-breaking attendance in 2018\, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 11th year in February 2019. \nWith 6 tracks spanning across 2 days\, the 2019 event is guaranteed to provide you with practical takeaways to help you accelerate your clinical trial timelines as well as insider knowledge on new innovations and technological advancements in the industry. \nFocused on enabling collaboration between the clinical trials community in the Bay Area\, the 2019 agenda is jam-packed with interactive sessions such as fireside chats\, panel discussions\, think-tanks and more. Whether you want to dive into a presentation on digital biomarkers or a panel discussion on measuring the health of your vendor partnerships\, there is something for everyone at the upcoming meeting. \nDon’t miss out on; join us in Burlingame on 12-13 February by registering your place today!
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-west-coast-2019/
LOCATION:Hyatt Regency San Francisco Airport Hotel  1333 Bayshore Highway  Burlingame  94010
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190219
DTEND;VALUE=DATE:20190221
DTSTAMP:20260515T013656
CREATED:20180926T073514Z
LAST-MODIFIED:20180926T073514Z
UID:17758-1550534400-1550707199@www.pharmajournalist.com
SUMMARY:Pharma Security Asia 2019
DESCRIPTION:The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas\, strengthening the importance of adequate drug research and development activities. However\, with the growth of the industry in Asia comes the increase in fake drugs. In recent times\, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO)\, about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate\, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.\nWe require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters.\nThus\, To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nSocial Media: \n@corvusglobal\nhttps://www.facebook.com/corvusglobalevents/\nhttps://twitter.com/corvusglobal?lang=en
URL:https://www.pharmajournalist.com/event/pharma-security-asia-2019/
LOCATION:Singapore\, Singapore
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190219
DTEND;VALUE=DATE:20190222
DTSTAMP:20260515T013656
CREATED:20181123T082750Z
LAST-MODIFIED:20181123T082750Z
UID:18485-1550534400-1550793599@www.pharmajournalist.com
SUMMARY:7th World CNS Summit
DESCRIPTION:The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. \n \nWorld CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees\, helping to overcome the translational challenges in developing efficacious therapeutics. \nDeveloped in combination with experts from Biogen\, Eisai\, Merck\, AbbVie and other leading organizations\, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting. \nFollowing numerous neurodegenerative disease clinical failures\, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success. \nNow in its 7th successful year\, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration\, bringing together over 150+ leading minds in the neurodegenerative space\, from academia\, pharma\, biotech and leading consortia\, to provide a unique opportunity to bridge the gap of translational drug development. \nTo learn more and to register online\, visit http://bit.ly/2AfTc9J
URL:https://www.pharmajournalist.com/event/7th-world-cns-summit/
LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190222
DTSTAMP:20260515T013656
CREATED:20181025T121157Z
LAST-MODIFIED:20181025T121157Z
UID:18118-1550620800-1550793599@www.pharmajournalist.com
SUMMARY:3rd Annual 3D Cell Culture
DESCRIPTION:SMi’s 3rd Annual 3D Cell Culture\nDelivering updates on the development and application of human organs and tissues in vitro\n \nProudly sponsored by InoCure & TEDD Competence Centre \nCHAIRED BY: \nNicola Valeri\, Gastrointestinal Cancer Biology and Genomics Team Leader\, The Institute of Cancer Research\nStefan Przyborski\, Professor of Cell Technology\, University of Durham \nCell Culture in an important tool for research and development within the life science industry. Over the past few years\, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions\, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring\, cell viability\, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans. \n \nResearchers globally are realizing the potential of 3D cell culture for various applications\, including testing and discovering new drugs to treat cancer\, organ-on-chip models to study the human physiology in an organ specific context\, and 3D cell printing to produce organ models. Therefore\, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022\, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting\, funding from governments and private entities and technological advancements in the field. \nAt the 3D Cell Culture Conference in February\, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts\, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development\, discuss the potential for novel in-vitro cell culture models to replace animal models\, and discover novel 3D cell culture systems\, organ-on-chip\, 3D imaging of organoids and other technologies in development. \nEvent Hashtag: #SMi3DCellCulture \nFEATURED SPEAKERS INCLUDE: \nGUEST SPEAKER: \n\nBill Mattes\, Director\, Division of Systems Biology\, FDA \n\nSPEAKERS INCLUDE: \n\nAsli Akidil\, Cell and Molecular Scientist\, AstraZeneca\nGary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Biosciences\nJason Ekert\, Head of Complex In Vitro Models\, GSK\nPhilip Hewitt\, UK and Eurotox Registered Toxicologist\, Head of Early Investigative Technology\, Merck\nStefan Kustermann\, Lab Head\, Investigative Safety\, Roche\nVeronique Barban\, Expert Virology\, Research and Nonclinical Safety Department\, Sanofi Pasteur\n\nKEY TOPICS FOR 2018 INCLUDE: \n\nOrgan-on-chip technologies and their applications in the pharmaceutical industry\nPanel discussion on whether 3D Cell Culture will replace animal models\nDetermining the predictive validity of 3D models and achieving standardization for preclinical testing\nGlobal developments in 3D Cell Culture and how this exponential growth will impact researchers\nSeveral novel techniques for imaging of 3D Cell Cultures\nDevelopment of 3D eye models for early assessment of retinal toxicity\nMusculoskeletal regeneration harnessing preclinical models for tissue repair\n\nView the full agenda: http://www.3d-cellculture.com/pjwl \nWHO SHOULD ATTEND \nBiotech / Pharma Companies – Team Leader\, Junior Principle investigator\, Cell and Molecular Scientist\, Chief Scientific Officer\, Deputy Director\, Manager\, Founder\, CEO\, Head\, Director\, Programme Manager\, Lab Head\, Toxicologist \nAcademia Professor – Cell Technology\, Stem Cell Sciences\, Biochemistry\, Protein Technology and Tissue Engineering \nSolution Providers – Manager\, Head of\, CEO\, Director\, Founder\, Account Manager\, President\, CSO\, Executive\, Managing Director\, Vice President\, COO \nOrganisations / Regulatory – Director\, Senior Science Advisor\, Scientific Officer  \nEARLY BIRD-RATES \n\nBOOK BY 31ST OCTOBER AND SAVE £400\nBOOK BY 30TH NOVEMBER AND SAVE £200\nBOOK BY 14TH DECEMBER AND SAVE £100
URL:https://www.pharmajournalist.com/event/3rd-annual-3d-cell-culture/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190222
DTSTAMP:20260515T013656
CREATED:20181119T145121Z
LAST-MODIFIED:20181119T145121Z
UID:18459-1550620800-1550793599@www.pharmajournalist.com
SUMMARY:Pharma Packaging and Labeling East Coast 2019
DESCRIPTION:Now in its 11th year\, Pharma Packaging and Labeling is back to deliver key\, actionable insights into very latest regulatory requirements\, technological innovations\, strategic developments\, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost. \n \nWith evolving regulations and tougher anti-counterfeiting rules\, ensuring patient safety and the right systems are in place is more crucial than ever. Meeting the deadlines and adhering to regulations will not only ensure compliance but will also deliver huge benefits to your business and the industry \nWith popular demand\, the US Drug Enforcement Agency will be back to answer questions on current anti-counterfeit regulations and how this will impact your business. The 2019 speaker line up brings together regulatory bodies and pharma companies including the DSCSA\, US Customs & Borders\, Pfizer\, Merck\, Trevena\, Biogen\, Alkermes and an insight into CMOs including PharmoRx Therapeutics\, among many others. \nPharma Packaging and Labeling will bring you everything you need to ensure a successful and compliant implementation for your packaging and labeling. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more\, this event will create an environment where commercial packaging and labeling teams from across all sizes of manufacturer can work together to manage creative\, technical\, and regulatory demands while ensuring patients are safeguarded at all stages. \nFor more details\, please visit http://www.arena-international.com/pharmapackagingeast/
URL:https://www.pharmajournalist.com/event/pharma-packaging-and-labeling-east-coast-2019/
LOCATION:Philadelphia\, Pennsylvania
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190227
DTSTAMP:20260515T013656
CREATED:20181206T111248Z
LAST-MODIFIED:20181206T111248Z
UID:18683-1551052800-1551225599@www.pharmajournalist.com
SUMMARY:3rd European Clinical Quality Oversight Forum
DESCRIPTION:The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting\, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing\, optimising and managing the quality of clinical vendors and sites. \n \nTo learn more about this event\, visit https://goo.gl/uPWwum
URL:https://www.pharmajournalist.com/event/3rd-european-clinical-quality-oversight-forum/
LOCATION:Hilton London Canary Wharf\, South Quay\, Marsh Wall\, London\, E14 9SH\, United Kingdom
ORGANIZER;CN="ExL Events":MAILTO:contact@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190228
DTSTAMP:20260515T013656
CREATED:20190103T104014Z
LAST-MODIFIED:20190103T104149Z
UID:18924-1551052800-1551311999@www.pharmajournalist.com
SUMMARY:CAR-TCR Summit Europe
DESCRIPTION:The industry-focused CAR-TCR Summit Europe is dedicated to developing\, translating and delivering next generation CAR and TCR therapies for patients in Europe. \n \nJoin over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting\, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted\, efficacious and commercially viable cancer therapy. \nFor more information\, visit www.cartcr-europe.com
URL:https://www.pharmajournalist.com/event/car-tcr-summit-europe/
LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190227
DTSTAMP:20260515T013656
CREATED:20190108T100940Z
LAST-MODIFIED:20190108T100940Z
UID:18951-1551052800-1551225599@www.pharmajournalist.com
SUMMARY:Global NASH Congress
DESCRIPTION:Attracting experts working in all areas of nonalcoholic steatohepatitis\, the Global NASH Congress will examine the latest research and development in pathogenesis\, diagnosis\, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year\, and the primary method of treatment is weight loss. With no approved medicines on the market\, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood\, and definitive diagnostic methods are invasive\, so development has been slow. There are\, however\, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models\, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements\, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development.
URL:https://www.pharmajournalist.com/event/global-nash-congress/
LOCATION:London\, United Kingdom\, London Heathrow Marriott Hotel\, London\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190226
DTEND;VALUE=DATE:20190301
DTSTAMP:20260515T013656
CREATED:20190213T093921Z
LAST-MODIFIED:20190214T153157Z
UID:19523-1551139200-1551398399@www.pharmajournalist.com
SUMMARY:AsiaTIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:AsiaTIDES is the only event in Asia that brings together the science\, technologies and partners you need to accelerate your oligonucleotide and peptide molecules to market. Join 300+ scientists and executives at this upcoming meeting featuring keynote speakers from Novo Nordisk A/S\, Ionis Pharmaceuticals\, Alnylam Pharmaceuticals\, and WAVE Life Sciences. \n \nRegister now at www.AsiaTIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/asiatides-oligonucleotide-peptide-therapeutics/
LOCATION:Hilton Tokyo Bay Hotel | Tokyo\, Japan
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T013656
CREATED:20181206T112043Z
LAST-MODIFIED:20181206T112357Z
UID:18687-1552348800-1552607999@www.pharmajournalist.com
SUMMARY:CPhI South East Asia 2019
DESCRIPTION:CPhI South East Asia will move to Bangkok\, Thailand in March 12-14 for the first time. Featuring the co-located with FDF\, ICSE\, P-MEC\, InnoPack\, and LABworld South East Asia\, CPhI South East Asia 2019 will host more than 6\,000 attendees and 270 exhibitors. CPhI South East Asia offers you the chance to do business in a booming and expanding market\, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics. \nWhether you are looking for sourcing new business or getting the latest market insight\, this is your ONE-STOP – SHOP pharmaceutical platform in South East Asia. \nTo learn more about this event\, visit www.cphi.com/sea
URL:https://www.pharmajournalist.com/event/cphi-south-east-asia-2019/
LOCATION:Queen Sirikit National Convention Center (QSNCC)\, 60 New Rachadapisek Road\, Klongtoey\, Bangkok\, 10110\, Thailand
ORGANIZER;CN="UBM Asia (Thailand)":MAILTO:Nureen.c@ubm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190314
DTSTAMP:20260515T013656
CREATED:20190215T073218Z
LAST-MODIFIED:20190215T073413Z
UID:19570-1552348800-1552521599@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Israel 2019
DESCRIPTION:Arena International is thrilled to announce that the fifth Outsourcing in Clinical Trials conference is returning to Tel Aviv\, 12th – 13th March\, 2019\, the only clinical outsourcing platform for biotech\, pharmaceutical and medical device companies within Israel. \nAs with its reputation\, this conference addresses how companies can effectively develop their outsourcing strategies and attendees with attain an increased understanding of how to enhance their operational efficiencies to ensure timely and cost-effective clinical studies. \nThis conference is equally an exclusive place in which delegate will network with industry professionals and service providers\, as well as attending insightful lectures from senior representatives from entrepreneurial companies within the Israeli Life Sciences sector. \nWe invite you to join us in March 2019\, register your place today.
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-israel-2019/
LOCATION:We are pleased to announce the venue is now confirmed. To request the venue details please contact us at events@arena-international.com
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T013656
CREATED:20181128T145347Z
LAST-MODIFIED:20181128T145347Z
UID:18574-1552435200-1552607999@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics in Biopharmaceuticals Europe 2019
DESCRIPTION:Facilitating a platform for the pharmaceutical industry to refine their temperature controlled logistics strategy to ensure an overall successful supply chain \n \nThe 15th Annual Temperature Controlled Logistics in Biopharmaceuticals returns to Milan\, after an extremely successful 2018 event. The largest European clinical and commercial pharmaceutical supply chain will bring together industry experts to examine the ever changing market and how these new dynamics will impact how the sector operates. \nOur 2019 agenda will focus on providing a holistic approach to the pharmaceutical supply chain to ensure the quality\, efficacy and safety of your product during temperature controlled shipments. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nKey topics for 2019 will include: \n\nDeveloping risk mitigation management plans\nRefining your shipping lines to reduce temperature deviations\nAdding metrics whilst comparing air\, rail and sea distribution to determine the best transportation method for each product\nSeparating the hype to give rise to practical tangible solutions of how to incorporate blockchain into your supply chain\n\nJoin us in March to be a part of the discussions to refine your temperature controlled logistics strategy. Click here to book your place now
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-in-biopharmaceuticals-europe-2019/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T013656
CREATED:20181128T145711Z
LAST-MODIFIED:20181128T145711Z
UID:18580-1552435200-1552607999@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Europe 2019
DESCRIPTION:This year’s Clinical Trial Supply Europe celebrates its 20th year! As a result of this special occasion we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s incredibly successful conference and are returning with full force to Milan with the aim of supporting trial sponsors and solution providers across Europe to ensure trials are delivered on time\, partnerships are improved and supply chain uncertainties are resolved. \n \nWe will once again be meeting in Milan\, Italy\, to discuss\, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s largest CTS conference this event promises to be a must attend for the industry! \nAt each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies\, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies\, thought leading presentations and engaging panels. \nThis year we will be looking at issues such as\, but not limited to discovering the practical benefits of e-labelling; how this technological innovation can expedite packaging and labelling timelines\, ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and whether blockchain’s time come? Is blockchain a buzzword or an actionable tool for disrupting operations? \nWith such a packed program you can’t afford to miss out. We look forward to meeting you in Milan so make sure to book your place today!
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-europe-2019/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190314
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T013656
CREATED:20190121T082920Z
LAST-MODIFIED:20190208T080646Z
UID:19169-1552521600-1552607999@www.pharmajournalist.com
SUMMARY:2nd Annual Pharma Regulatory Summit 2019
DESCRIPTION:Pharma Regulatory Summit is the leading platform for regulatory experts\, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. This conference will focus on the new strategies\, amendments\, innovations\, developments in the fields of regulatory affairs\, intellectual property and medical devices\, which reflects new strategies in the field of regulatory affairs. \nSPONSORS: \n\nExhibitor: Nishith Desai Associates\n\nCONFERENCE REGISTRATION PROCESS: \nE-mail – kavitha@virtueinsight.co.in  Tel: +9144 24762472 \n\nEarly Bird Discount Price (Ends 28th January 2019) – (INR 10\,000 + GST (18%) per delegate)\nStandard Price (From 29th January 2019 Onwards) – (INR 15\,000 + GST (18%) per delegate)\nSponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together.
URL:https://www.pharmajournalist.com/event/2nd-annual-pharma-regulatory-summit-2019/
LOCATION:Kohinoor Continental Hotel\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260515T013656
CREATED:20181022T121303Z
LAST-MODIFIED:20181022T121355Z
UID:18094-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:21st Annual Superbugs & Superdrugs Conference
DESCRIPTION:As the global threat of antimicrobial resistance continues to grow\, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. \n \nSMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London\, UK for its 21st year running\, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities\, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections. \nThe two-day conference will also host a diverse gathering of policy makers and economists\, in addition to big pharmas and biotechs\, who will discuss incentives\, partnerships\, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data\, as well as alternatives to antibiotics\, such as monoclonal antibodies and antimicrobial peptides.  \n2019 HIGHLIGHTS:  \n\nAnalyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR\nHear about novel immune-therapeutics to target Gram-negative bacterial infections\nLearn about strategies to combat β-lactamases\nEvaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship\nExplore the role of plasmids in the evolution of antimicrobial resistance\n\nJoin us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance\, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures\, University of Oxford\, MedImmune\, HPRA\, GARDP\, DNDi\, Bioharmony Therapeutics\, and many more.  \nEarly Bird Discounts!  \nBook by November 30th and save £400\nBook by December 14th and save £200\nBook by January 31st and save £100  \nFor more information and to register online\, please visit http://www.superbugssuperdrugs.com/pjwl
URL:https://www.pharmajournalist.com/event/21st-annual-superbugs-superdrugs-conference/
LOCATION:HOLIDAY INN KENSINGTON FORUM\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:mmandic@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260515T013656
CREATED:20181029T164425Z
LAST-MODIFIED:20181029T164425Z
UID:18183-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:3rd Annual Drug Discovery Chemistry
DESCRIPTION:SMi’s 3rd Annual Drug Discovery Chemistry  \nDeveloping your R&D pipeline with strategies to deliver small molecules  \nConference: 18 – 19 March 2019\nWorkshop: 20 March 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nWebsite: www.drug-discovery.co.uk/PJwl \nCHAIRED BY: \nRoderick Hubbard\, Senior Fellow\, Vernalis Research Ltd\nDarren Green\, Director of Molecular Design\, GSK \nSMi is proud to present its 3rd Annual Drug Discovery Chemistry event\, taking place on the 18th-19th March 2019. \n \nThe fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market\, however\, demand for novel drugs is still steadily increasing.M \nThis year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines\, with optimization of the R&D process to become cheaper\, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present\, as the process is overall long\, expensive and often potential drugs will fail late in clinical trials\, wasting resources and time. \nThe event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted\, and likewise\, offer new drug targets for existing diseases that could potentially offer better clinical outcomes\, such as within the development of cancer drugs. \nDrug Discovery Chemistry 2019 will look at various developments within the field\, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines\, reduce their R&D cost and timelines\, and ultimately\, increase their medicine output for commercial success. \nEvent Hashtag: #SMiDrugDisChem \nKEY SPEAKERS INCLUDE: \n\nVivek Vishnudas\, Senior Vice President Drug discovery & Platform Sciences\, Berg LLC\nTobias Gabriel\, Global Head of Discovery Chemistry\, Novartis\nGovinda Bhisetti\, Principal Investigator and Head of Computational Chemistry\, Biogen\nHasane Ratni\, Expert Scientist\, F Hoffmann-La Roche\nAlexander Hillisch\, Director of Medicinal Chemistry\, Bayer \n\nKEY TOPICS FOR 2018 INCLUDE: \n\nDiscuss the impact of the use of novel computational techniques on R&D pipelines\nHear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment\nDiscover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process\nExplore the potential of new modalities to transform therapeutics\nLearn about current strategies to increase drug discovery success \n\nPost conference workshop on 20 March 2019 \nArtificial Intelligence in Drug Discovery \nLed by: Nick Camp\, Consultant \nWHO SHOULD ATTEND \nCEOs\, Presidents\, Vice Presidents and Global Heads\, Executive Directors\, Vice President & Global head\, Principal Scientists\, Heads of Business Development\, Directors of Pharma/Biotech firms. \nEARLY BIRD-RATES \n\nBOOK BY 30 NOVEMBER AND SAVE £400\nBOOK BY 15 DECEMBER AND SAVE £200\nBOOK BY 31 JANUARY AND SAVE £100
URL:https://www.pharmajournalist.com/event/3rd-annual-drug-discovery-chemistry/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260515T013656
CREATED:20171108T010017Z
LAST-MODIFIED:20181122T123741Z
UID:3856-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:ProcureCon Pharma 2019
DESCRIPTION:Taking place on 19th-20th March 2019 in Frankfurt\, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies \n \nJoin 150+ senior procurement professionals from Merck\, AstraZeneca\, Roche\, Sanofi\, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions\, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma\, download the agenda. \nTake away solutions to all of your top challenges: \n\nMaster analytical and digital procurement in pharma\nBuild strategic partnerships with your internal stakeholders\nDesign and train a high-performing global pharma procurement team\nMove beyond savings with key CROS and CMOS to unlock hidden innovation\n\nFor more information including the incredible speaker line-up\, take a look at the conference brochure here: https://bit.ly/2yIP6a1 \nBook your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”
URL:https://www.pharmajournalist.com/event/procurecon-pharma-2019/
LOCATION:Steigenberger Frankfurter Hof\, Am Kaiserplatz\, Frankfurt/Main\, 60311\, Germany
ORGANIZER;CN="Worldwide Business Research":MAILTO:Procurecon@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260515T013656
CREATED:20181109T151157Z
LAST-MODIFIED:20181126T130220Z
UID:18365-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:ePharma IMPACT
DESCRIPTION:ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative\, next generation omni-channel strategies. \nThe 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact. \nHow do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships\, and greater influence over impactful marketing strategy. \nThe 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.
URL:https://www.pharmajournalist.com/event/epharma-impact/
LOCATION:NY Hilton 1335 Ave of the Americas New York\, NY 10017\, NY\, United States
ORGANIZER;CN="Knect365":MAILTO:register@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260515T013656
CREATED:20181214T104719Z
LAST-MODIFIED:20181214T104719Z
UID:18830-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:Pharma Security World 2019 - Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain\, Drug Serialization and Anti-Counterfeiting Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/pharma-security-world-2019-anti-counterfeiting-drug-serialization-and-supply-chain-security-conference/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260515T013656
CREATED:20190219T121841Z
LAST-MODIFIED:20190219T121841Z
UID:19638-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:Innate Killer Summit 2019
DESCRIPTION:Accelerate to Market Genetically Engineered\, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications \n The Innate Killer Summit 2019 discusses safer\, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy. \n \nIt will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability. \nBringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.
URL:https://www.pharmajournalist.com/event/innate-killer-summit-2019/
LOCATION:Hilton San Diego Gaslamp Quarter\, 401 K St\, San Diego\, CA 92101
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190329
DTSTAMP:20260515T013656
CREATED:20181126T151827Z
LAST-MODIFIED:20181126T151827Z
UID:18552-1553558400-1553817599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders
DESCRIPTION:Gene Therapy for Rare Disorders is a uniquely focused conference that unites the leaders in the field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future. \n \nIncorporating insights from 50+ industry-leading speakers\, the meeting delves into the key regulatory\, reimbursement\, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies. \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, Gene Therapy for Rare Disorders will present a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease. \nJoin 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy\, enhanced safety and commercial viability. \nTo learn more and to register online\, visit https://bit.ly/2ByuEe2
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders/
LOCATION:The Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T013656
CREATED:20190110T101919Z
LAST-MODIFIED:20190110T101919Z
UID:18980-1553558400-1553731199@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England 2019
DESCRIPTION:This year’s Clinical Trial Supply New England celebrates its 8th year and will be hosted on the 26th – 27th of March. \nIn 2019 we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s success conference and are returning with full force to Boston with the aim of supporting trial sponsors and solution providers across New England to ensure trials are delivered on time\, partnerships are improved and supply chain uncertainties are resolved. \nWe will once again be meeting in to discuss\, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s dedicated Clinical Trial Supply conference for the New England area\, this event caters to local needs while offering the change to meet international sponsors and solution providers. \nAt each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies\, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies\, thought leading presentations and engaging panels. \nThis year we will be looking at those issues which are affecting companies in the Boston-Cambridge hub\, such as but no limited to: ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain\, discovering how to incorporate gene therapies within your supply chain and blockchain: a discussion of practical applications for clinical supply chain and life-sciences. \nWith such a packed program you can’t afford to miss out. We look forward to meeting you in Boston so make sure to book your place today!
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190327
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T013656
CREATED:20190308T084926Z
LAST-MODIFIED:20190308T084926Z
UID:19867-1553644800-1553731199@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:The Pharma Gorilla will be held on March 27\, 2019 in Hilton Mumbai International Airport\, Mumbai\, India. It provides the opportunity to learn\, engage and network for the pharmaceutical and healthcare fraternity. This conference is designed to address practical issues and topics for Corporates\, scientists\, professors\, business representatives\, and healthcare providers to discuss the latest innovations\, trends and concerns\, practical challenges and solutions in Pharma. \nThe objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla/
LOCATION:Hilton Mumbai International Airport\, Mumbai\, India
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190401
DTEND;VALUE=DATE:20190403
DTSTAMP:20260515T013656
CREATED:20181121T114612Z
LAST-MODIFIED:20181130T122336Z
UID:18473-1554076800-1554249599@www.pharmajournalist.com
SUMMARY:Adaptive Designs in Clinical Trials 2019
DESCRIPTION:SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology. \n \nHosting in depth presentations from regulatory agencies\, researchers and biostatisticians\, the meeting will cover how personalized medicine\, platform trials\, response-adaptive randomization\, signature designs\, estimand framework\, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America. \nTo learn more and to register online\, visit www.adaptivedesigns.co.uk/pharmajwl
URL:https://www.pharmajournalist.com/event/adaptive-designs-in-clinical-trials-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T013656
CREATED:20181005T132158Z
LAST-MODIFIED:20181005T132334Z
UID:17940-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:17th annual eyeforpharma Philadelphia Conference
DESCRIPTION:Where pharma’s performance is built by patient value \nThe world’s greatest gathering of pharma’s value-designers \nEvery important industry player in one room\, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia\, the flagship event where pharma\, patients and payers co-design for outcomes. \nThere are dozens of events on digital\, on patient centricity\, on data\, on access\, on medical\, on commercial. Only one event brings all the key designers together so that we can address unmet need\, create solutions that cover the spectrum\, and end the age-old problems of misalignment. \nJoin us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2O8ldd5
URL:https://www.pharmajournalist.com/event/17th-annual-eyeforpharma-philadelphia-conference/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="eyeforpharma":MAILTO:jbramwell@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T013656
CREATED:20190108T073610Z
LAST-MODIFIED:20190108T073610Z
UID:18942-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:CAR-T Congress USA
DESCRIPTION:CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite\, the race is on to lead the commercialization of safe\, efficacious and accessible CAR-T therapy. \n \nThe fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions\, including MD Anderson and the University of Pennsylvania. \nHear first-hand\, the emerging areas of research from new companies into single patient experiences\, as well as context around patient relapses and methods of toxicity management. \nJoin thought leaders from biotechs\, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity\, scalability and efficacy in both liquid and solid tumours. \nDiscover how CAR-T compares to standard treatments and advances in genome editing tools\, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery. \nBe part of the movement that engineers a strategy to reprogram the cancer treatments we know today. \nBook before January 25 to save up to $800.  To learn more about this event and to book online visit: www.car-tcongress.com/register
URL:https://www.pharmajournalist.com/event/car-t-congress-usa/
LOCATION:Hyatt Regency Boston Harbor\, 101 Harborside Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260515T013656
CREATED:20190220T073216Z
LAST-MODIFIED:20190220T073349Z
UID:19646-1555372800-1555631999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit (NIDD)
DESCRIPTION:Built with thought-leaders at Sanofi\, Eisai\, AbbVie and Denali\, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. \n\nWith an emphasis on neurodegeneration\, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges: \n\nDiscover robust biomarkers of neuroinflammation to enable successful translation and patient stratification\nNavigate preclinical model limitations to better predict clinical efficacy\nExplore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches\n\nDon’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic. \nFor more information\, visit www.neuroimmunology-drugdevelopment.com
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-nidd/
LOCATION:Hyatt Regency Boston  One Avenue de Lafayette\, Boston  Massachusetts\, United States\, 02111
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190423
DTEND;VALUE=DATE:20190426
DTSTAMP:20260515T013656
CREATED:20190220T073616Z
LAST-MODIFIED:20190220T073737Z
UID:19651-1555977600-1556236799@www.pharmajournalist.com
SUMMARY:European NeoAg Summit
DESCRIPTION:With an exclusive case-study led agenda\, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity. \nIn addition\, gain practical insights on personalised cancer vaccine and cell therapy global clinical development\, as well as regulatory guidance. \nJoin the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm\, Genocea\, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies. \nFor more information\, visit www.neoantigen-europe.com 
URL:https://www.pharmajournalist.com/event/european-neoag-summit/
LOCATION:Amsterdam Marriot Hotel  Stadhouderskade 12\, 1054 ES  Amsterdam\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190430
DTEND;VALUE=DATE:20190502
DTSTAMP:20260515T013656
CREATED:20190110T103553Z
LAST-MODIFIED:20190110T110108Z
UID:18984-1556582400-1556755199@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to the West Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019. \nAs one of the only oncology operationally focused events in the West Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nWe hope to see you in April\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-the-west-coast-2019/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190509
DTSTAMP:20260515T013656
CREATED:20190201T151752Z
LAST-MODIFIED:20190201T151752Z
UID:19366-1557100800-1557359999@www.pharmajournalist.com
SUMMARY:2nd Annual CKD3 Summit
DESCRIPTION:Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need. \n \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research. \nTo learn more and to register online\, visit https://ter.li/10so2k
URL:https://www.pharmajournalist.com/event/2nd-annual-ckd3-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR